Hall et al. 2010 determined that women who had early onset DCIS had a significantly increased risk of BRCA1/BRCA2 mutation compared with women who had late‐onset disease (aged ≥50 years; OR, 1.5; 95% CI 1.1–2.1). This evidence concerns the gene BRCA2 and ductal breast carcinoma in situ.